JP2013505939A5 - - Google Patents

Download PDF

Info

Publication number
JP2013505939A5
JP2013505939A5 JP2012531018A JP2012531018A JP2013505939A5 JP 2013505939 A5 JP2013505939 A5 JP 2013505939A5 JP 2012531018 A JP2012531018 A JP 2012531018A JP 2012531018 A JP2012531018 A JP 2012531018A JP 2013505939 A5 JP2013505939 A5 JP 2013505939A5
Authority
JP
Japan
Prior art keywords
chloro
methyl
administered
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2012531018A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013505939A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/049946 external-priority patent/WO2011038082A1/en
Publication of JP2013505939A publication Critical patent/JP2013505939A/ja
Publication of JP2013505939A5 publication Critical patent/JP2013505939A5/ja
Ceased legal-status Critical Current

Links

JP2012531018A 2009-09-23 2010-09-23 組合せ Ceased JP2013505939A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24501909P 2009-09-23 2009-09-23
US61/245,019 2009-09-23
PCT/US2010/049946 WO2011038082A1 (en) 2009-09-23 2010-09-23 Combination

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015246931A Division JP2016106092A (ja) 2009-09-23 2015-12-18 組合せ

Publications (2)

Publication Number Publication Date
JP2013505939A JP2013505939A (ja) 2013-02-21
JP2013505939A5 true JP2013505939A5 (https=) 2013-11-14

Family

ID=43796197

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012531018A Ceased JP2013505939A (ja) 2009-09-23 2010-09-23 組合せ
JP2015246931A Pending JP2016106092A (ja) 2009-09-23 2015-12-18 組合せ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015246931A Pending JP2016106092A (ja) 2009-09-23 2015-12-18 組合せ

Country Status (14)

Country Link
US (2) US20120322817A1 (https=)
EP (1) EP2480084B1 (https=)
JP (2) JP2013505939A (https=)
KR (1) KR20120099219A (https=)
CN (1) CN102770026B (https=)
AU (1) AU2010298277B2 (https=)
BR (1) BR112012006693A2 (https=)
CA (1) CA2775124A1 (https=)
EA (1) EA021951B1 (https=)
ES (1) ES2527625T3 (https=)
IL (1) IL218797A (https=)
MX (1) MX2012003546A (https=)
WO (1) WO2011038082A1 (https=)
ZA (1) ZA201202173B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130217710A1 (en) * 2010-11-05 2013-08-22 Glaxosmithkline Intellectual Property (No.2) Limited Methods for treating cancer
TWI505828B (zh) 2010-12-20 2015-11-01 葛蘭素史克智慧財產(第二)有限公司 新穎醫藥組成物
TR201815685T4 (tr) * 2011-04-01 2018-11-21 Genentech Inc Kanser tedavisi için akt ve mek inhibe edici bileşiklerin kombinasyonları.
EP2913048A1 (en) 2014-02-27 2015-09-02 ratiopharm GmbH Pharmaceutical composition comprising trametinib
JP2020530498A (ja) * 2017-08-11 2020-10-22 キュアマッチ インコーポレイテッドCurematch, Inc. 癌における複数の変異を標的とする薬物の組み合わせ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ3401A1 (fr) * 2000-07-19 2002-01-24 Warner Lambert Co Esters oxygenes d'acides 4-iodophenylamino benzhydroxamiques
US7378423B2 (en) * 2004-06-11 2008-05-27 Japan Tobacco Inc. Pyrimidine compound and medical use thereof
AU2005252110B2 (en) * 2004-06-11 2008-09-04 Shionogi & Co., Ltd. 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyrido[2,3-D] pyrimidine derivatives and related compounds for the treatment of cancer
JP3821154B1 (ja) * 2005-03-16 2006-09-13 いすゞ自動車株式会社 排気ガス浄化方法及び排気ガス浄化システム
UY30892A1 (es) * 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt

Similar Documents

Publication Publication Date Title
JP2013509429A5 (https=)
JP2009513662A5 (https=)
JP2015536964A5 (https=)
JP2016539156A5 (https=)
JP2017518302A5 (https=)
JP2013505939A5 (https=)
JP2016536286A5 (https=)
JP2012193216A5 (https=)
PH12015502134A1 (en) Mosapride sustained-release preparation for providing pharmacological and clinical effects with once-a-day administration
JP2015523397A5 (https=)
JP2014526503A5 (https=)
JP2014521735A5 (https=)
JP2014534269A5 (https=)
JP2016517888A5 (https=)
NZ596739A (en) Methods of treating proliferative diseases
JP2014526456A5 (https=)
JP2011507896A5 (https=)
JP2014505107A5 (https=)
JP2012522841A5 (https=)
JP2008535785A5 (https=)
JP2012503602A5 (https=)
JP2015507020A5 (https=)
JP2015514757A5 (https=)
JP2013544892A5 (https=)
JP2013523740A5 (https=)